drugset / Trial / NCT07858643
A Study of LDGraft In Single Level Lumbar Interbody Fusion
NaSingle-groupOpen-labelTreatment
Summary
The objective of the study is to evaluate the safety and effectiveness of LDGraft (investigational device) when applied in a lumbar interbody fusion procedure in the treatment of patients with lumbar Degenerative Disc Disease (DDD).
Timeline
- Start
- 2026-04-08
- Primary completion
- 2027-10
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rhBMP-2 | Protein / enzyme biologic | — | — |